Creative Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . Creative Medical Technology
CELZ Stock  USD 2.04  0.07  3.55%   
Creative Medical's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Creative Medical's valuation are provided below:
Gross Profit
3.6 K
Quarterly Earnings Growth
3.589
Market Capitalization
6.9 M
Enterprise Value Revenue
251.4973
Revenue
6 K
We have found one hundred twenty available fundamental signals for Creative Medical Technology, which can be analyzed and compared to other ratios and to its rivals. All investors should make sure to validate all of Creative Medical Technology prevailing market performance against the performance between 2010 and 2026 to make sure the company can sustain itself down the road. Market Cap is likely to rise to about 5.5 M in 2026, whereas Enterprise Value is likely to drop (2.4 M) in 2026.

Creative Medical Total Revenue

12,017.5

Check Creative Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Creative Medical's main balance sheet or income statement drivers, such as Selling General Administrative of 3.9 M, Other Operating Expenses of 6.9 M or Total Operating Expenses of 6.9 M, as well as many indicators such as Price To Sales Ratio of 159, Dividend Yield of 0.0039 or PTB Ratio of 0.65. Creative financial statements analysis is a perfect complement when working with Creative Medical Valuation or Volatility modules.
  
Build AI portfolio with Creative Stock
Check out the analysis of Creative Medical Correlation against competitors.

Creative Medical Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets8.1 M7.7 M3.9 M
Slightly volatile
Total Current Liabilities358 K376.8 K3.7 M
Pretty Stable
Accounts Payable366.7 K314.6 K392.4 K
Slightly volatile
Common Stock Shares Outstanding1.8 M1.7 M462.2 K
Slightly volatile
Liabilities And Stockholders Equity8.1 M7.7 M3.9 M
Slightly volatile
Other Stockholder Equity85.6 M81.6 M28.5 M
Slightly volatile
Total Liabilities358 K376.8 K3.7 M
Pretty Stable
Total Current Assets7.4 M7.1 M3.6 M
Slightly volatile
Common Stock1.9 K2 K118.9 K
Very volatile
Cash7.2 M6.8 M2.5 M
Slightly volatile
Cash And Short Term Investments7.2 M6.8 M3.5 M
Slightly volatile
Short and Long Term Debt Total15.5 K16.3 K228.4 K
Very volatile
Short Term Debt15.5 K16.3 K224.5 K
Very volatile
Other Liabilities2.6 K3.7 K2.5 K
Slightly volatile
Non Current Assets Total422 K613.9 K299.6 K
Slightly volatile
Long Term Debt78282410.8 K
Slightly volatile
Short and Long Term Debt692 K907 K500 K
Slightly volatile
Intangible Assets420.4 K610.1 K298.5 K
Slightly volatile
Capital Stock1.5 K1.6 K527.9 K
Slightly volatile
Other Assets0.860.92.3 K
Slightly volatile

Creative Medical Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Selling General Administrative3.9 M3.7 M1.5 M
Slightly volatile
Other Operating Expenses6.9 M6.6 M2.6 M
Slightly volatile
Total Operating Expenses6.9 M6.6 M2.6 M
Slightly volatile
Interest Expense109.6 K115.4 K571.3 K
Pretty Stable
Depreciation And Amortization64.7 K127 K45.7 K
Slightly volatile
Reconciled Depreciation71.2 K127 K48.7 K
Slightly volatile

Creative Medical Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow4.2 M4 M1.8 M
Slightly volatile
End Period Cash Flow7.2 M6.8 M2.5 M
Slightly volatile
Depreciation133.4 K127 K49.8 K
Slightly volatile
Dividends Paid3.8 M4.3 M4.7 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio159280252
Pretty Stable
Dividend Yield0.00390.00430.0047
Slightly volatile
Days Sales Outstanding11.2911.89179
Slightly volatile
Average Payables525.8 K500.7 K283.4 K
Slightly volatile
Stock Based Compensation To Revenue7.243.8315.7875
Slightly volatile
Capex To Depreciation1.621.221.6123
Very volatile
Inventory Turnover2.682.313.7229
Slightly volatile
Days Of Inventory On Hand213164138
Slightly volatile
Payables Turnover0.01760.01854.7909
Slightly volatile
Sales General And Administrative To Revenue8.078.592.1708
Slightly volatile
Research And Ddevelopement To Revenue20619679.3312
Slightly volatile
Capex To Revenue10.510.03.4964
Slightly volatile
Cash Per Share4.384.61222
Pretty Stable
Payout Ratio0.00120.00130.0014
Slightly volatile
Days Payables Outstanding10.7 K20.4 K8.9 K
Slightly volatile
Intangibles To Total Assets0.08690.09150.323
Slightly volatile
Current Ratio17.716.855.9414
Slightly volatile
Receivables Turnover33.3731.7817.1899
Slightly volatile
Capex Per Share0.07760.081730.4446
Slightly volatile
Average Receivables1.4 K1.4 K3.1 K
Slightly volatile
Revenue Per Share0.00810.008525.7473
Slightly volatile
Interest Debt Per Share0.01050.0112.2 K
Slightly volatile
Debt To Assets0.00230.002478.9586
Slightly volatile
Graham Number279293306
Slightly volatile
Operating Cycle169164262
Slightly volatile
Days Of Payables Outstanding10.7 K20.4 K8.9 K
Slightly volatile
Dividend Payout Ratio0.00120.00130.0014
Slightly volatile
Quick Ratio17.6916.855.9385
Slightly volatile
Net Income Per E B T1.651.181.1662
Pretty Stable
Cash Ratio17.1316.324.5049
Slightly volatile
Days Of Inventory Outstanding213164138
Slightly volatile
Days Of Sales Outstanding11.2911.89179
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.321.161.1758
Pretty Stable
Debt Ratio0.00230.002478.9586
Slightly volatile
Price Sales Ratio159280252
Pretty Stable
Asset Turnover0.00180.00190.0594
Very volatile

Creative Medical Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap5.5 M3.9 M5.4 M
Slightly volatile

Creative Fundamental Market Drivers

Creative Upcoming Events

29th of March 2024
Upcoming Quarterly Report
View
10th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
29th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Creative Medical Financial Statements

Creative Medical investors use historical fundamental indicators, such as Creative Medical's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Creative Medical. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue-16.3 K-15.5 K
Total Revenue12.7 K12 K
Cost Of Revenue4 K3.8 K
Stock Based Compensation To Revenue 3.83  7.24 
Sales General And Administrative To Revenue 8.50  8.07 
Research And Ddevelopement To Revenue 196.43  206.25 
Capex To Revenue 10.00  10.50 
Revenue Per Share 0.01  0.01 
Ebit Per Revenue(600.49)(570.47)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
JBLJabil Circuit
MRKMerck Company
AMGNAmgen Inc

Additional Tools for Creative Stock Analysis

When running Creative Medical's price analysis, check to measure Creative Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Creative Medical is operating at the current time. Most of Creative Medical's value examination focuses on studying past and present price action to predict the probability of Creative Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Creative Medical's price. Additionally, you may evaluate how the addition of Creative Medical to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY